KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Total Debt (2016 - 2020)

Neogenomics filings provide 11 years of Total Debt readings, the most recent being $95.6 million for Q1 2020.

  • On a quarterly basis, Total Debt rose 642.68% to $95.6 million in Q1 2020 year-over-year; TTM through Mar 2020 was $95.6 million, a 642.68% increase, with the full-year FY2019 number at $96.8 million, up 1.12% from a year prior.
  • Total Debt hit $95.6 million in Q1 2020 for Neogenomics, down from $96.8 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $98.1 million in Q2 2018 to a low of $5.0 million in Q2 2019.
  • Median Total Debt over the past 5 years was $30.7 million (2017), compared with a mean of $46.5 million.
  • Biggest five-year swings in Total Debt: crashed 94.9% in 2019 and later soared 642.68% in 2020.
  • Neogenomics' Total Debt stood at $25.5 million in 2016, then increased by 10.63% to $28.3 million in 2017, then soared by 238.76% to $95.8 million in 2018, then grew by 1.12% to $96.8 million in 2019, then fell by 1.26% to $95.6 million in 2020.
  • The last three reported values for Total Debt were $95.6 million (Q1 2020), $96.8 million (Q4 2019), and $6.2 million (Q3 2019) per Business Quant data.